EMEA-001430-PIP01-13
Key facts
| Active substance |
Anti proprotein convertase subtilisin kexin type 9 humanized monoclonal antibody (PF-04950615)
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0080/2014
|
| PIP number |
EMEA-001430-PIP01-13
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Pfizer Limited
E-mail: pip_enquiries@pfizer.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|